Health Catalyst, Inc.HCATEarnings & Financial Report
Nasdaq · Information Technology · Services-Computer Programming, Data Processing, Etc.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 9.20% | 5.3M | — | 2024-01-24 |
| First Light Asset Management, LLC | 8.63% | 5.2M | — | 2024-11-14 |
| The Vanguard Group | 7.57% | 4.6M | flat | 2024-11-12 |
| Wellington Management Group LLP | 3.20% | 1.9M | ▼ -2.38pp | 2024-11-08 |
| Point72 Asset Management, L.P. | 1.00% | 619.0K | ▼ -6.20pp | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-01 | Larson-Green Julie | Director | Grant | 8.4K | $0.00 | $0 |
| 2026-02-25 | Benjamin Albert | CEO | Grant | 930.0K | $0.00 | $0 |
| 2026-02-25 | Benjamin Albert | CEO | Grant | 38.8K | $0.00 | $0 |
| 2026-02-25 | Linda Llewelyn | Chief People Officer | Grant | 191.5K | $0.00 | $0 |
| 2026-02-25 | Linda Llewelyn | Chief People Officer | Grant | 13.2K | $0.00 | $0 |
| 2026-02-25 | Jason Alger | Chief Financial Officer | Grant | 507.5K | $0.00 | $0 |
| 2026-02-25 | Jason Alger | Chief Financial Officer | Grant | 22.2K | $0.00 | $0 |
| 2026-02-25 | Benjamin Landry | General Counsel | Grant | 289.0K | $0.00 | $0 |
| 2026-02-25 | Benjamin Landry | General Counsel | Grant | 16.5K | $0.00 | $0 |
| 2026-02-17 | Duncan Gallagher | Director | Grant | 7.6K | $0.00 | $0 |
1–10 of 10